Device Valvulotom

Hydro Lemaitre Valvulotome

Payments companies reported to CMS as associated with Hydro Lemaitre Valvulotome. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$299Kassociated payments (2023-2025)
784clinicians with associated payments
1company reporting

By year

2023 $60K
2024 $41K
2025 $199K

Payments reported as associated with Hydro Lemaitre Valvulotome, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $171K
Vascular Surgery $89K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $29K
Physician Assistant $3,058
Nurse Practitioner $2,306
Family $722

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hydro Lemaitre Valvulotome

These are the largest totals companies reported as associated with Hydro Lemaitre Valvulotome. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mark Keldahl Chicago, IL Surgery $132,677.00
William Raible Albany, NY Surgery $28,223.00
Mohamed Abdel Halim Mohamed Cleveland, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $16,215.41
Atif Baqai Park Ridge, IL Vascular Surgery $11,436.47
George Koullias East Patchogue, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $11,424.40
Thomas Bernik New York, NY Vascular Surgery $10,500.00
Steven Elias Englewood, NJ Vascular Surgery $10,000.00
Tejas Shah Downers Grove, IL Vascular Surgery $6,292.87
Benjamin Chang Williamsport, PA Vascular Surgery $5,043.41
Michael Lieb Hainesport, NJ Vascular Surgery $4,083.42

Prescribed Hydro Lemaitre Valvulotome?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.